Oslo (Norway), 12 April 2018 – Exercise of employee share options and resolution to increase the share capital in PCI Biotech Holding ASA (the “Company”).
1. Options exercised
One participant in the Company’s share option program has on 12th April 2018 exercised a total number of 5,000 share options at a strike price of NOK 9.11 and a total number of 3,000 share options at a strike price of NOK 3.79, corresponding to a total number of 8,000 shares.
2. Resolution to increase the share Capital
Following the exercise of share options on 12 April 2018, the Company’s Board of Directors, pursuant to an authorisation granted by the Company’s Annual General Meeting on May 29 2017, has decided to increase the Company’s share capital with NOK 24,000 by issuing 8,000 new shares, each share of par value NOK 3.00. Subsequent to the transaction, the Company’s share capital will be NOK 74,984,670 divided into 24,994,890 shares. The capital increase will result in gross proceeds of NOK 56,920.
Ronny Skuggedal, CFO
Mobile: +47 9400 5757